Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

L.A. McKeown

May 28, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Daily News

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

Michael O'Riordan

February 05, 2020

Advertisement

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Even Low-Dose Steroids Increase the Risk of CVD

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Just One-Third of European Patients Get to LDL Cholesterol Goals

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

TCTMD’s Top 10 Most Popular Stories for September 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content